Korean Circ J.  2020 Mar;50(3):234-235. 10.4070/kcj.2020.0041.

Optimal Timing of Coronary Intervention in Non-Culprit Lesion in ST Elevation Myocardial Infarction with Multi-Vessel Disease

• Seo J
• Kim JS

• KMID: 2470907
• DOI: http://doi.org/10.4070/kcj.2020.0041

Abstract

No abstract available.

MeSH Terms

Myocardial Infarction*

Reference

1. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369:1115–1123.

2. Kwon SW, Park SD, Moon J, et al. Complete versus culprit-only revascularization for ST-segment elevation myocardial infarction and multivessel disease in the 2nd generation drug-eluting stent era: data from the interstellar registry. Korean Circ J. 2018; 48:989–999.

3. Ahn KT, Oh JK, Seong SW, et al. One-year clinical outcomes between single- versus multi-staged PCI for ST elevation myocardial infarction with multi-vessel coronary artery disease: from Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH). Korean Circ J. 2020; 50:220–233.

4. Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with st-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39:119–177.

5. Kim I, Kim MC, Jeong HC, et al. Optimal timing of percutaneous coronary intervention for nonculprit vessel in patients with ST-segment elevation myocardial infarction and multivessel disease. Korean Circ J. 2017; 47:36–43.